Intercure Ltd.
Business
InterCure Ltd. is an Israeli pharmaceutical-cannabis company that breeds, cultivates, manufactures and distributes pharmaceutical-grade cannabis and cannabis-based products for medical use. The company produces standardized cannabis products with defined cannabinoid profiles in dried and oil delivery formats, certified to GMP standards. InterCure operates production facilities in Israel, owns or operates a chain of 26 medical-cannabis-focused pharmacies across Israel, the UK and Austria, and has established distribution partnerships and joint ventures in Europe and Canada for future expansion into regulated markets.
Summary from 20-F filed 2026-04-30
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $-36.78M |
| Total assets | $690.55M |
| Total liabilities | $294.19M |
| Stockholders' equity | — |
| Operating cash flow | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Intercure Ltd.'s CIK number?
Intercure Ltd.'s SEC CIK number is 0001857030 (1857030). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Intercure Ltd.'s SEC filings?
All of Intercure Ltd.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.